| Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial A Pels, J Derks, A Elvan-Taspinar, J van Drongelen, M de Boer, ... JAMA network open 3 (6), e205323-e205323, 2020 | 105 | 2020 |
| Number of patients studied prior to approval of new medicines: a database analysis RG Duijnhoven, SMJM Straus, JM Raine, A de Boer, AW Hoes, ... PLoS medicine 10 (3), e1001407, 2013 | 101 | 2013 |
| Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial JKJ Keulen, A Bruinsma, JC Kortekaas, J van Dillen, PMM Bossuyt, ... BMJ 364, l344, 2019 | 98 | 2019 |
| Marketing authorization applications made to the european medicines agency in 2018–2019: what was the contribution of real‐world evidence? R Flynn, K Plueschke, C Quinten, V Strassmann, RG Duijnhoven, ... Clinical Pharmacology & Therapeutics 111 (1), 90-97, 2022 | 86 | 2022 |
| Potential misinterpretation of treatment effects due to use of odds ratios and logistic regression in randomized controlled trials MJ Knol, RG Duijnhoven, DE Grobbee, KGM Moons, RHH Groenwold PLoS One 6 (6), e21248, 2011 | 69* | 2011 |
| Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials M Alkmark, JKJ Keulen, JC Kortekaas, C Bergh, J Van Dillen, ... PLoS medicine 17 (12), e1003436, 2020 | 45 | 2020 |
| Effect of single‐versus double‐layer uterine closure during caesarean section on postmenstrual spotting (2Close): multicentre, double‐blind, randomised controlled superiority trial SI Stegwee, LF Van der Voet, AJ Ben, RA De Leeuw, PM Van De Ven, ... BJOG: An International Journal of Obstetrics & Gynaecology 128 (5), 866-878, 2021 | 37 | 2021 |
| Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe NS Vermeer, RG Duijnhoven, S Straus, AK Mantel‐Teeuwisse, PR Arlett, ... Clinical Pharmacology & Therapeutics 96 (6), 723-731, 2014 | 37 | 2014 |
| Post-approval safety issues with innovative drugs: a European cohort study PGM Mol, AH Arnardottir, D Motola, PJ Vrijlandt, RG Duijnhoven, ... Drug safety 36, 1105-1115, 2013 | 36 | 2013 |
| Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding P Beelen, MJ van den Brink, MC Herman, PMAJ Geomini, JH Dekker, ... American journal of obstetrics and gynecology 224 (2), 187. e1-187. e10, 2021 | 32 | 2021 |
| Long-term use of 5α-reductase inhibitors and the risk of male breast cancer RG Duijnhoven, SMJM Straus, PC Souverein, A de Boer, JLHR Bosch, ... Cancer Causes & Control, 1-6, 2014 | 31 | 2014 |
| Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study LR Van der Vaart, A Vollebregt, AL Milani, AL Lagro‐Janssen, ... BJOG: An International Journal of Obstetrics & Gynaecology 129 (5), 820-829, 2022 | 24 | 2022 |
| Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data JC Naafs, LM Vendrig, J Limpens, HJ Van Der Lee, RG Duijnhoven, ... European Journal of Endocrinology 182 (3), 351-361, 2020 | 22 | 2020 |
| Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study JP Fournier, RG Duijnhoven, C Renoux, S Dell’Aniello, OH Klungel, ... Menopause 21 (9), 1023-1026, 2014 | 13 | 2014 |
| The CErebro Placental RAtio as indicator for delivery following perception of reduced fetal movements, protocol for an international cluster randomised clinical trial; the … SE Damhuis, W Ganzevoort, RG Duijnhoven, H Groen, S Kumar, ... BMC pregnancy and childbirth 21, 1-8, 2021 | 12 | 2021 |
| Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial RLO Van de Laar, W Hofhuis, RG Duijnhoven, S Polinder, WJG Melchers, ... BMC cancer 20, 1-7, 2020 | 12 | 2020 |
| Child outcomes after amnioinfusion compared with no intervention in women with second‐trimester rupture of membranes: a long‐term follow‐up study of the PROMEXIL‐III trial AA de Ruigh, NE Simons, J van't Hooft, AS van Teeffelen, RG Duijnhoven, ... BJOG: An International Journal of Obstetrics & Gynaecology 128 (2), 292-301, 2021 | 11 | 2021 |
| Effect of pessary vs surgery on patient-reported improvement in patients with symptomatic pelvic organ prolapse: a randomized clinical trial LR van der Vaart, A Vollebregt, AL Milani, AL Lagro-Janssen, ... Jama 328 (23), 2312-2323, 2022 | 10 | 2022 |
| Temporizing management vs immediate delivery in early‐onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open‐label randomized controlled trial JJ Duvekot, RG Duijnhoven, E van Horen, CJ Bax, KW Bloemenkamp, ... Acta obstetricia et gynecologica Scandinavica 100 (1), 109-118, 2021 | 9 | 2021 |
| Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre … TJ Oderkerk, P Beelen, PMAJ Geomini, MC Herman, JC Leemans, ... BMC Women's Health 22 (1), 257, 2022 | 6 | 2022 |
Ben Willem MolProfessor of Obstetrics and Gynaecology, Monash UniversityVerified email at monash.edu
